LATEST

Off the Wire

IN FOCUS

Tumor Cell ‘Homing’ and the Mastectomy vs. Lumpectomy Debate

Notable breast surgeon and researcher, Dr. Kefah Mokbel, is advocating the benefits of breast-conserving therapy over mastectomy in certain patients, based on a combination of clinical evidence...

The Growing Role of Advanced PET Imaging in Breast Cancer Care

Positron Emission Tomography (PET) is becoming an increasingly important tool in managing breast cancer. This shift is largely due to more PET radiotracers being approved by the...

New Research Shines Light on Hormone Therapy Resistance in Breast Cancer

Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment. A key breakthrough from...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...

Study Unveils Cancer Causing Chemicals Among Women Workers

Breast cancer is a major health issue in California, being the most common and the second deadliest cancer among women in the state. Nearly...

Alpelisib Linked to Higher Diabetic Ketoacidosis Risk in Breast Cancer Patients

Alpelisib, a drug used with another medication called fulvestrant to treat a specific type of advanced breast cancer targets a part of the cancer...

Study Links Air Pollution to More Severe Breast Cancer Cases

A groundbreaking study has revealed a concerning connection between air pollution and the severity of breast cancer, shedding light on how our environment could...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is...

DRUG DEVELOPMENT